Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 02 October, 2012

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 7289N
GlaxoSmithKline PLC
02 October 2012
 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in the directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

 

On 28 September 2012, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £14.37 per Ordinary Share, and notional ADSs at a price of $46.52 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2012 to 30 September 2012:

 

Non Executive Director

Ordinary Shares

American Depositary Shares (ADSs)

Sir Christopher Gent

2,348.643


Professor Sir Roy Anderson

456.681


Dr Stephanie Burns


443.463

Stacey Cartwright

326.200


Sir Crispin Davis

1,652.749


Lynn  Elsenhans


  570.166

Judy Lewent


221.731

Sir Deryck Maughan


886.925

Dr Daniel Podolsky


855.249

Tom de Swaan

674.148


Jing Ulrich


158.379

Sir Robert Wilson

456.681


 

The Company and the Non-Executive Directors were informed of these allocations on 1 October 2012.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

V A Whyte

Company Secretary

2 October 2012

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLLFBLBFEFBV

a d v e r t i s e m e n t